Related Experiment Video
Updated: Jul 10, 2025

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Altered fecal bile acid composition in active ulcerative colitis
Stefanie Sommersberger1, Stefan Gunawan1, Tanja Elger1
1Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053, Regensburg, Germany.
Fecal bile acids show altered levels in inflammatory bowel diseases (IBD), with specific changes in ulcerative colitis (UC) linked to disease severity and diarrhea. These findings may help differentiate IBD subtypes and understand UC symptoms.
Area of Science:
- Gastroenterology
- Metabolomics
- Clinical Diagnostics
Background:
- Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are characterized by disrupted bile acid homeostasis.
- The diagnostic and prognostic value of fecal bile acids in IBD remains unclear.
Purpose of the Study:
- To investigate associations between 18 fecal bile acid species and IBD diagnosis, disease activity, and symptoms.
- To explore the potential of fecal bile acids as biomarkers for distinguishing IBD subtypes.
Main Methods:
- Quantification of 18 fecal bile acid species in stool samples from 62 IBD patients and 17 controls using LC-MS/MS.
- Analysis of bile acid levels normalized to dry weight and ratios to total bile acids.
- Correlation analysis with clinical markers like fecal calprotectin and C-reactive protein (CRP).
Main Results:
- IBD patients displayed altered primary and secondary fecal bile acid profiles, differing between UC and CD.
- In UC, specific bile acids (glycolithocholic acid, hyodeoxycholic acid) correlated negatively with fecal calprotectin and were reduced in severe cases.
- Reduced deoxycholic acid, glycine conjugated DCA, and lithocholic acid were observed in UC patients with diarrhea; GHDCA and glycochenodeoxycholic acid showed potential for distinguishing UC from CD.
Conclusions:
- Disrupted fecal bile acid homeostasis is linked to disease severity and diarrhea in UC, but not CD.
- Fecal bile acid profiles may aid in differentiating UC from CD and understanding the pathophysiology of diarrhea in UC.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

